Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

CAPS Rating: 2 out of 5

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.

Recs

0
Player Avatar crapsshooter (97.05) Submitted: 4/21/2010 1:43:04 PM : Outperform Start Price: $3.71 ARIA Score: +340.11

good presntation. good results. good prospects only upside do i see

Featured Broker Partners


Advertisement